Design and analysis of controlled clinical trials in rheumatic diseases.
作者信息
Williams H J, Reading J C, Ward J R
出版信息
Clin Rheum Dis. 1983 Dec;9(3):499-514.
PMID:6606530
Abstract
Controlled clinical trials can be difficult, expensive, and time-consuming, but are necessary to advance the knowledge concerning rheumatic disease. Proper care in the design of the study and appropriate statistical analysis of the data can result in studies that answer specific questions and are well worth the effort and expense. If the design is well planned before the entry of the first patient, many problems will be avoided and the results will be credible.
摘要
相似文献
1
Design and analysis of controlled clinical trials in rheumatic diseases.
Clin Rheum Dis. 1983 Dec;9(3):499-514.
2
Interpreting clinical trials of antirheumatic drug therapy.抗风湿药物治疗的临床试验解读
Bull Rheum Dis. 1986;36(2):1-10.
3
Perspectives on clinical trials in the rheumatic diseases.对风湿性疾病临床试验的见解。
Clin Rheum Dis. 1983 Dec;9(3):491-8.
4
[Methodological deficiencies in clinical trials].[临床试验中的方法学缺陷]
Fortschr Med. 1992 Oct 10;110(28):511-4.
5
Methods of randomization in controlled clinical trials.对照临床试验中的随机化方法。
Am J Emerg Med. 1985 Sep;3(5):467-73. doi: 10.1016/0735-6757(85)90207-4.
6
The principles of controlled clinical trials of drugs.
Int J Clin Pharmacol Biopharm. 1978 Aug;16(8):361-4.
7
An efficient design for phase III studies of combination chemotherapies.
Cancer Treat Rep. 1985 Oct;69(10):1147-54.
8
Design and analysis of prostate cancer trials.前列腺癌试验的设计与分析。
Acta Urol Belg. 1994 Apr;62(1):23-9.
9
A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches.一种用于开发和选择临床试验指标的方法框架：统计方法和判断方法。
J Rheumatol. 1982 Sep-Oct;9(5):753-7.
10
Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials.癌症临床试验中的资格排除、失访、随机分组患者的剔除以及未计数事件。
Cancer Treat Rep. 1985 Oct;69(10):1107-13.
Zotero 插件